NTRK-fusions in pediatric thyroid tumors: Current state and future perspectives.

Cancer Genet

Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, 816-C, Philadelphia, PA 19104, United States; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States. Electronic address:

Published: June 2022

Pediatric and adult papillary thyroid cancer (PTC) share many similar oncogenic drivers, but differ in the pathological features and outcomes of the disease. The most frequent genetic alterations in adult PTCs are mutually exclusive point mutations in BRAF or the RAS family. In pediatric PTC, fusion oncogenes involving chromosomal translocations in tyrosine kinase (TK) receptors, most commonly RET and NTRK, are the most common genetic alterations observed. This review of the literature describes the current state of translational research in pediatric NTRK-driven thyroid cancer and highlights opportunities to improve our understanding and current models of pediatric PTC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133211PMC
http://dx.doi.org/10.1016/j.cancergen.2022.02.009DOI Listing

Publication Analysis

Top Keywords

current state
8
thyroid cancer
8
genetic alterations
8
pediatric ptc
8
ntrk-fusions pediatric
4
pediatric thyroid
4
thyroid tumors
4
tumors current
4
state future
4
future perspectives
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!